H Schramm

3.4k total citations · 1 hit paper
42 papers, 2.5k citations indexed

About

H Schramm is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, H Schramm has authored 42 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 14 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in H Schramm's work include Pancreatic and Hepatic Oncology Research (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Gastrointestinal disorders and treatments (5 papers). H Schramm is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Gastrointestinal disorders and treatments (5 papers). H Schramm collaborates with scholars based in Germany, Switzerland and Netherlands. H Schramm's co-authors include Karsten Ridwelski, Wolf O. Bechstein, Hanno Riess, Klaus Gellert, Helmut Oettle, Stefan Post, Jan M. Langrehr, J. Fahlke, Carl Zuelke and E. Kettner and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Annals of Surgery.

In The Last Decade

H Schramm

35 papers receiving 2.4k citations

Hit Papers

Adjuvant Chemotherapy With Gemcitabine vs Observation in ... 2007 2026 2013 2019 2007 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H Schramm Germany 9 2.1k 1.1k 785 715 551 42 2.5k
Osamu Kainuma Japan 20 1.6k 0.7× 983 0.9× 789 1.0× 412 0.6× 310 0.6× 80 2.1k
Jörg Fahlke Germany 9 1.3k 0.6× 732 0.7× 650 0.8× 394 0.6× 421 0.8× 21 1.6k
J. Fahlke Germany 10 2.0k 0.9× 943 0.9× 924 1.2× 690 1.0× 543 1.0× 28 2.3k
Bernd Doerken Germany 10 1.8k 0.8× 729 0.7× 672 0.9× 661 0.9× 509 0.9× 19 2.1k
L. Roll Germany 4 1.7k 0.8× 736 0.7× 650 0.8× 665 0.9× 530 1.0× 8 1.9k
Ralf Wilkowski Germany 25 1.3k 0.6× 448 0.4× 533 0.7× 502 0.7× 524 1.0× 48 1.8k
Kenjiro Kotake Japan 26 1.9k 0.9× 993 0.9× 771 1.0× 357 0.5× 194 0.4× 116 2.6k
Spiros Hiotis United States 20 713 0.3× 815 0.8× 444 0.6× 488 0.7× 285 0.5× 62 1.8k
Knut Jørgen Labori Norway 24 1.2k 0.6× 697 0.7× 501 0.6× 323 0.5× 284 0.5× 102 1.6k
Pamela J. Hodul United States 28 2.0k 0.9× 805 0.8× 811 1.0× 743 1.0× 423 0.8× 91 2.3k

Countries citing papers authored by H Schramm

Since Specialization
Citations

This map shows the geographic impact of H Schramm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Schramm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Schramm more than expected).

Fields of papers citing papers by H Schramm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H Schramm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Schramm. The network helps show where H Schramm may publish in the future.

Co-authorship network of co-authors of H Schramm

This figure shows the co-authorship network connecting the top 25 collaborators of H Schramm. A scholar is included among the top collaborators of H Schramm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Schramm. H Schramm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oettle, Helmut, Stefan Post, P. Neuhaus, et al.. (2007). Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer. JAMA. 297(3). 267–267. 1754 indexed citations breakdown →
2.
Langrehr, Jan M., Helmut Oettle, Stefan Post, et al.. (2006). ADJUVANT CHEMOTHERAPY WITH GEMCITABINE VERSUS OBSERVATION FOR RESECTED CARCINOMA OF THE PANCREATIC HEAD. Pancreas. 33(4). 475–475. 1 indexed citations
3.
Stroh, Christine, et al.. (2005). Langzeitergebnisse nach Gastric Banding. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 130(5). 410–418. 6 indexed citations
4.
Will, Uwe, et al.. (2004). Endoscopic treatment of a pseudocystocolonic fistula by band ligation and endoloop application: case report. Gastrointestinal Endoscopy. 59(4). 581–583. 18 indexed citations
5.
Schramm, H, et al.. (2003). Milzläsionen im Rahmen der chronischen Pankreatitis durch Milzvenenverschluss und durch Zystenpenetration. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 128(5). 434–437. 2 indexed citations
6.
Schramm, H, et al.. (2003). Seltene Befunde am Pankreas. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 128(5). 429–433. 1 indexed citations
7.
Kornmann, Marko, Wolfgang Schwabe, Silvia Sander, et al.. (2003). Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.. PubMed. 9(11). 4116–24. 136 indexed citations
8.
Kretzschmar, Michael, et al.. (2003). Intraoperative Neurolyse des Plexus celiacus bei Patienten mitnichtresektablem Pankreaskarzinom. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 128(5). 419–423. 6 indexed citations
9.
Schramm, H, et al.. (2002). Intrasurgical Pancreas Cytology. Pancreas. 24(2). 210–214. 8 indexed citations
10.
Lorenz, Matthias, Eugen Mattes, H.‐J. Gassel, et al.. (2001). Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas. Annals of Oncology. 12(3). 321–325. 8 indexed citations
11.
Kretzschmar, Moritz, et al.. (2001). Intraoperative Diagnose eines präoperativ symptomlosen Phäochromozytoms bei Morbus Recklinghausen. Der Anaesthesist. 50(2). 113–117. 2 indexed citations
12.
Jünemann, K.-P., et al.. (2001). Gefahren des monopolaren Stroms in der laparoskopischen Gallenblasenchirurgie. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 126(8). 591–595. 5 indexed citations
13.
Stroh, Christine & H Schramm. (2000). Postoperative Kontrolle und Gewichtsverhalten nach Gastric Banding. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 125(8). 682–687. 2 indexed citations
14.
Schramm, H, et al.. (2000). [The upside-down stomach. Laparoscopic treatment is possible].. PubMed. 125(4). 394–7. 2 indexed citations
15.
Schramm, H, et al.. (1999). The infantile inguinal hernia - a bilateral disease?. Pediatric Surgery International. 15(2). 115–118. 20 indexed citations
16.
Schramm, H, et al.. (1999). Akute Cholecystitis – primär laparoskopisches Vorgehen. Der Chirurg. 70(3). 270–275. 2 indexed citations
17.
Gassel, H.‐J., et al.. (1998). [Intra-arterial (5-FU/FA and FUDR) versus systemic chemotherapy (5-FU/FA) of non-resectable colorectal liver metastases].. PubMed. 115. 1458–60. 2 indexed citations
18.
Schramm, H, et al.. (1992). Successful treatment of a Candida albicans sepsis with a combination of flucytosine and fluconazole. Mycoses. 35(11-12). 315–316. 13 indexed citations
19.
Frigg, M. & H Schramm. (1977). Comparative anticoccidial activity of lasalocid sodium*) (Avatec®) in chicks: Efficacy against european strains of coccidia. Archiv für Geflügelkunde. 41. 31–34. 1 indexed citations
20.
Schramm, H, et al.. (1969). [Primary carcinoma of the appendix].. PubMed. 94(26). 869–71. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026